Trial intelligence / Profile preview

Mucoadhesive Tacrolimus Patch for Oral Lichen Planus

NCT05139667Phase 4Completed

Sponsor
Ain Shams University
Start
May 2019
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Tacrolimus Ointment 0.1% Iwaki in oral lichen planus (OLP) (3 arms), sponsored by Ain Shams University. Primary endpoint: Clinical Score at 12 weeks. Started May 2019; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT05139667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05139667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call